Compass Pathways, which is developing a psilocybin treatment for severe depression, said it now expects an earlier decision ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel ...

Biotech raises $540M from DRW, ARK Invest for Canton Coin treasury. Shares surge 120% on Super Validator plans.

Lab equipment maker Waters Corp raised its annual profit forecast on Tuesday, after beating third-quarter profit estimates on ...

Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for Metsera ...

Human trials could begin as early as this month at all three Mayo Clinic locations — in Florida, Minnesota and Arizona — with patients who are newly diagnosed with glioblastoma. The first phase of the ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Pfizer has launched a second lawsuit against Novo Nordisk over its $9 billion bid for biotech company Metsera. Pfizer accuses ...

KB407 utilizes a replication-defective HSV-1 vector to deliver full-length CFTR to the airway epithelium. The interim readout ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...